Skip to main content
Premium Trial:

Request an Annual Quote

Supreme Court Upholds Invalidation of ABL-held Informatics Patents

Premium

NEW YORK (GenomeWeb) – Last week, SmartGene said that the United States Supreme Court has denied an attempt by Advanced Biological Laboratories to vacate a favorable ruling from the US Court of Appeals for the Federal Circuit related to two ABL patents that have been the subject of a seven-year lawsuit between both companies.

The ABL patents in question — both of which cover computerized methods for selecting treatment regimens for patients with known diseases — were initially invalidated by the US District Court for the District of Columbia. ABL appealed the decision but in February this year the US Court of Appeals upheld the district court's ruling. ABL then petitioned the Supreme Court which has now denied its claim.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.